MannKind Corp (NASDAQ:MNKD)

3.68
Delayed Data
As of May 20
 +0.17 / +4.84%
Today’s Change
2.49
Today|||52-Week Range
5.53
-15.79%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$929.4M

Company Description

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Contact Information

MannKind Corp.
1 Casper Street
Danbury Connecticut 06810
P:(818) 661-5000
Investor Relations:

Employees

Shareholders

Individual stakeholders4.54%
Mutual fund holders23.60%
Other institutional21.51%

Top Executives

Michael E. CastagnaChief Executive Officer & Director
Steven B. BinderChief Financial & Accounting Officer
Joseph KocinskyChief Technology Officer
Kevin KaisermanVice President-Medical Affairs & Safety
Thomas HofmannChief Scientific Officer